Hong Z, Huang X, Xia L, Liang T, Bai X
J Exp Clin Cancer Res. 2025; 44(1):68.
PMID: 39994761
PMC: 11849219.
DOI: 10.1186/s13046-025-03323-9.
Bhambri S, Jha P
Mol Divers. 2025; .
PMID: 39847188
DOI: 10.1007/s11030-025-11107-8.
Zhang X, Jin T, Wang H, Han S, Liang Y
Front Pharmacol. 2024; 15:1499799.
PMID: 39669194
PMC: 11635611.
DOI: 10.3389/fphar.2024.1499799.
Mehta K, Hegde M, Girisa S, Vishwa R, AlQahtani M, Abbas M
Mil Med Res. 2024; 11(1):76.
PMID: 39668367
PMC: 11636053.
DOI: 10.1186/s40779-024-00582-z.
Larose A, Miller C, Morotz G
Cell Mol Life Sci. 2024; 81(1):447.
PMID: 39520508
PMC: 11550312.
DOI: 10.1007/s00018-024-05480-0.
Structures and pH-dependent dimerization of the sevenless receptor tyrosine kinase.
Cerutti G, Arias R, Bahna F, Mannepalli S, Katsamba P, Ahlsen G
Mol Cell. 2024; 84(23):4677-4690.e6.
PMID: 39510067
PMC: 11625006.
DOI: 10.1016/j.molcel.2024.10.017.
PTK7: an underestimated contributor to human cancer.
Jin Z, Guo T, Zhang X, Wang X, Liu Y
Front Oncol. 2024; 14:1448695.
PMID: 39474113
PMC: 11518688.
DOI: 10.3389/fonc.2024.1448695.
Identification of potential bioactive phytochemicals for the inhibition of platelet-derived growth factor receptor β: a structure-based approach for cancer therapy.
Habib I, Sulaimani M, Jairajpuri D, Hussain A, Mohammad T, Alajmi M
Front Mol Biosci. 2024; 11:1492847.
PMID: 39473823
PMC: 11518818.
DOI: 10.3389/fmolb.2024.1492847.
Receptor tyrosine kinases in breast cancer treatment: unraveling the potential.
Qi Y, Deng S, Wang K
Am J Cancer Res. 2024; 14(9):4172-4196.
PMID: 39417188
PMC: 11477839.
DOI: 10.62347/KIVS3169.
Gastric Cancer Signaling Pathways and Therapeutic Applications.
Wu M, Yuan S, Liu K, Wang C, Wen F
Technol Cancer Res Treat. 2024; 23:15330338241271935.
PMID: 39376170
PMC: 11468335.
DOI: 10.1177/15330338241271935.
Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy.
Kumar R, Goel H, Solanki R, Rawat L, Tabasum S, Tanwar P
Med Drug Discov. 2024; 23.
PMID: 39281823
PMC: 11393807.
DOI: 10.1016/j.medidd.2024.100195.
Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies.
Ou X, Gao G, Habaz I, Wang Y
MedComm (2020). 2024; 5(9):e694.
PMID: 39184861
PMC: 11344283.
DOI: 10.1002/mco2.694.
Mechanisms of tropomyosin 3 in the development of malignant tumors.
Chen A, Li S, Gui J, Zhou H, Zhu L, Mi Y
Heliyon. 2024; 10(15):e35723.
PMID: 39170461
PMC: 11336884.
DOI: 10.1016/j.heliyon.2024.e35723.
Genetic code expansion, click chemistry, and light-activated PI3K reveal details of membrane protein trafficking downstream of receptor tyrosine kinases.
Koh D, Stratiievska A, Jana S, Otto S, Swanson T, Nhim A
Elife. 2024; 12.
PMID: 39162616
PMC: 11335347.
DOI: 10.7554/eLife.91012.
Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A
Signal Transduct Target Ther. 2024; 9(1):201.
PMID: 39138146
PMC: 11323831.
DOI: 10.1038/s41392-024-01899-w.
Nonsmall-cell lung cancer treatment: current status of drug repurposing and nanoparticle-based drug delivery systems.
Inci T, Acar S, Turgut-Balik D
Turk J Biol. 2024; 48(2):112-132.
PMID: 39051063
PMC: 11265851.
DOI: 10.55730/1300-0152.2687.
Functional Investigation of Mutations in Multiple Myeloma.
Heredia-Guerrero S, Evers M, Keppler S, Schwarzfischer M, Fuhr V, Rauert-Wunderlich H
Cancers (Basel). 2024; 16(11).
PMID: 38893258
PMC: 11171363.
DOI: 10.3390/cancers16112139.
Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?.
Kollipara S, Chougule M, Boddu R, Bhatia A, Ahmed T
AAPS J. 2024; 26(4):66.
PMID: 38862853
DOI: 10.1208/s12248-024-00939-1.
Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect.
Chompunud Na Ayudhya C, Graidist P, Tipmanee V
Sci Rep. 2024; 14(1):12531.
PMID: 38822100
PMC: 11143223.
DOI: 10.1038/s41598-024-63505-x.
Liver Diseases: From Bench to Bedside.
Kanda T, Sasaki-Tanaka R, Terai S
Int J Mol Sci. 2024; 25(10).
PMID: 38791491
PMC: 11121884.
DOI: 10.3390/ijms25105454.